Enhanced Skin Permeation of 5α-Reductase Inhibitors Entrapped into Surface-Modified Liquid Crystalline Nanoparticles

    August 2014 in “ Archives of Pharmacal Research ”
    Thiagarajan Madheswaran, Rengarajan Baskaran, Pasupathi Sundaramoorthy, Bong Kyu Yoo
    Image of study
    TLDR Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.
    In the 2014 study, researchers found that surface-modified liquid crystalline nanoparticles (sm-LCN) with chitosan enhanced the skin permeation of finasteride and dutasteride, which are 5α-reductase inhibitors used to treat androgenetic alopecia. The sm-LCNs showed a larger size and positive zeta potential, which contributed to a 1.7- to 4.2-fold increase in drug permeation through porcine skin compared to unmodified LCNs. The study also observed a controlled and delayed drug release from sm-LCNs and confirmed the non-toxicity of the ingredients at concentrations up to 20 µg/ml. The findings suggest that sm-LCNs could improve the topical application of these drugs, maximizing therapeutic effects while minimizing systemic side effects. The research was supported by the Gachon University research fund of 2014.
    Discuss this study in the Community →

    Research cited in this study

    14 / 14 results

    Related Community Posts Join

    6 / 162 results

      community Finasteride and “anti-aging” effects

      in Treatment  218 upvotes 3 months ago
      Finasteride may help users look younger by suppressing DHT, affecting skin and hair. Users also emphasize skincare, sunscreen, and lifestyle for maintaining a youthful appearance.

      community My Theory Of Androgenic Alopecia

      in Research/Science  17 upvotes 2 weeks ago
      Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community NW5 at 19. How many grafts do I need?

      in Transplants  138 upvotes 2 years ago
      A 19-year-old with rapid hair loss since 16 is considering a hair transplant but refuses to take finasteride or any 5α-Reductase inhibitors. They are currently using minoxidil, tretinoin, and microneedling with a Derminator 2, and only want hair until age 27.
      Can I still save my hairline at age of 15?

      community Can I still save my hairline at age of 15?

      in General  478 upvotes 3 weeks ago
      A 15-year-old is concerned about hair loss, possibly at Norwood 2 or 3, and is using shampoos and conditioners recommended by a trichologist. Suggestions include considering topical minoxidil and consulting a doctor about topical anti-DHT treatments like finasteride or RU58841, but avoiding 5-alpha-reductase inhibitors at this age.

    Similar Research

    5 / 1000+ results